Diabetic retinopathy: newer therapies to prevent blindness.
Scott M. Friedman, Melvin L. Rubin
Abstract
Scott M. Friedman, Melvin L. Rubin
Abstract
Diabetic retinopathy is a common cause of blindness in the adult population in the United States. Ophthalmologists now have laser and surgical treatment modalities available that can significantly decrease the risk of blindness in the diabetic population. The American Academy of Ophthalmology, through its Diabetes 2000 program, is making a national effort to educate all physicians who care for diabetic patients to recognize the problem and to be aware of the therapies available to prevent blindness.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Diabetic retinopathy is a common cause of blindness in the adult population in the United States. Ophthalmologists now have laser and surgical treatment modalities available that can significantly decrease the risk of blindness in the diabetic population. The American Academy of Ophthalmology, through its Diabetes 2000 program, is making a national effort to educate all physicians who care for diabetic patients to recognize the problem and to be aware of the therapies available to prevent blindness.
Key concepts: Medicine, Diabetic retinopathy, Blindness, Diabetes mellitus, Modalities, Population, Optometry, Retinopathy